HAL vs LENZ · P/E 9.3, $19.05B cap vs $223.6M cap
Halliburton Company (HAL) versus LENZ Therapeutics Inc (LENZ) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
LENZ does not have a complete income-statement cache yet.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. LENZ currently screens at market cap $223.6M.
Not investment advice. Open the HAL and LENZ stock pages for the full models.
Not investment advice.